CX3CR1 IDENTIFIES PD-1 THERAPY-RESPONSIVE CD8+ T CELLS THAT WITHSTAND CHEMOTHERAPY DURING CANCER CHEMOIMMUNOTHERAPY ArticleYan Y., Adjei A.A., Mansfield A.S., Markovic S.N., Dronca R.S., Cao S., Liu X., Harrington S.M., Bindeman W.E., Dong H., Jang J.S., Jen J., Li Y., Chanana P., Park S.S.JCI Insight. Том 3. 2018.
